JP2023542985A5 - - Google Patents
Info
- Publication number
- JP2023542985A5 JP2023542985A5 JP2023518779A JP2023518779A JP2023542985A5 JP 2023542985 A5 JP2023542985 A5 JP 2023542985A5 JP 2023518779 A JP2023518779 A JP 2023518779A JP 2023518779 A JP2023518779 A JP 2023518779A JP 2023542985 A5 JP2023542985 A5 JP 2023542985A5
- Authority
- JP
- Japan
- Prior art keywords
- arg
- phe
- trp
- hcys
- pen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082867P | 2020-09-24 | 2020-09-24 | |
| US63/082,867 | 2020-09-24 | ||
| PCT/US2021/052032 WO2022067086A1 (en) | 2020-09-24 | 2021-09-24 | Methods of treating melanocortin-4 receptor pathway-associated disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542985A JP2023542985A (ja) | 2023-10-12 |
| JP2023542985A5 true JP2023542985A5 (https=) | 2024-10-02 |
Family
ID=80845850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518779A Pending JP2023542985A (ja) | 2020-09-24 | 2021-09-24 | メラノコルチン－４受容体経路関連障害の治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240058414A1 (https=) |
| EP (1) | EP4216979A4 (https=) |
| JP (1) | JP2023542985A (https=) |
| KR (1) | KR20230095956A (https=) |
| CN (1) | CN116507353A (https=) |
| AR (1) | AR123603A1 (https=) |
| AU (1) | AU2021350017A1 (https=) |
| CA (1) | CA3192873A1 (https=) |
| CL (1) | CL2023000823A1 (https=) |
| CO (1) | CO2022009561A2 (https=) |
| MX (1) | MX2023003360A (https=) |
| TW (1) | TW202228760A (https=) |
| WO (1) | WO2022067086A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4554607A2 (en) * | 2022-07-12 | 2025-05-21 | Rhythm Pharmaceuticals, Inc. | Methods for treating obesity with an mc4r agonist |
| WO2024108198A2 (en) * | 2022-11-18 | 2024-05-23 | Rhythm Pharmaceuticals, Inc. | Methods of treating obesity with an mc4r agonist |
| TW202535448A (zh) * | 2023-11-14 | 2025-09-16 | 美商律森製藥股份有限公司 | 鉀通道活化劑與mc4r促效劑之組合及相關使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ565217A (en) * | 2005-07-08 | 2010-03-26 | Ipsen Pharma Sas | Melanocortin receptor ligands |
| EP2970388B1 (en) * | 2013-03-15 | 2018-07-25 | Rhythm Pharmaceuticals, Inc. | Peptide compositions |
| PL3356386T3 (pl) * | 2015-09-30 | 2024-08-05 | Rhythm Pharmaceuticals, Inc. | Sposób leczenia zaburzeń związanych ze szlakiem receptora melanokortyny 4 |
-
2021
- 2021-09-24 AU AU2021350017A patent/AU2021350017A1/en active Pending
- 2021-09-24 US US18/028,117 patent/US20240058414A1/en active Pending
- 2021-09-24 MX MX2023003360A patent/MX2023003360A/es unknown
- 2021-09-24 KR KR1020237013822A patent/KR20230095956A/ko active Pending
- 2021-09-24 CA CA3192873A patent/CA3192873A1/en active Pending
- 2021-09-24 TW TW110135665A patent/TW202228760A/zh unknown
- 2021-09-24 CN CN202180071771.8A patent/CN116507353A/zh active Pending
- 2021-09-24 JP JP2023518779A patent/JP2023542985A/ja active Pending
- 2021-09-24 WO PCT/US2021/052032 patent/WO2022067086A1/en not_active Ceased
- 2021-09-24 AR ARP210102664A patent/AR123603A1/es unknown
- 2021-09-24 EP EP21873549.6A patent/EP4216979A4/en active Pending
-
2022
- 2022-07-07 CO CONC2022/0009561A patent/CO2022009561A2/es unknown
-
2023
- 2023-03-22 CL CL2023000823A patent/CL2023000823A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12285460B2 (en) | Pharmaceutical compositions | |
| Eaves et al. | Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats | |
| JP2023542985A5 (https=) | ||
| JP2021102650A5 (https=) | ||
| JP2018531937A5 (https=) | ||
| US20080090757A1 (en) | Kahalalide Compositions for the Treatment of Psoriasis | |
| WO2017183559A1 (ja) | 薬物の経粘膜吸収促進剤 | |
| CN108697758B (zh) | 用于有效控制急性和/或慢性疼痛的药物及其施用方法 | |
| US11167005B2 (en) | Peptides for treating Sjogren's syndrome | |
| RU2025100211A (ru) | Способы лечения ожирения агонистом mc4r | |
| RU2022132255A (ru) | Способ лечения нарушений, ассоциированных с путем рецептора меланокортина 4 | |
| AU2008203708B2 (en) | Use of somatostatin analogs in cluster headache | |
| HK40046859A (en) | Pharmaceutical compositions | |
| HK40073416A (en) | Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers | |
| HK1220702B (en) | Pharmaceutical compositions |